Growth Metrics

Merck (MRK) Other financing activities (2016 - 2026)

Merck has reported Other financing activities over the past 18 years, most recently at -$80.0 million for Q1 2026.

  • Quarterly Other financing activities fell 33.33% to -$80.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$151.0 million through Mar 2026, up 57.34% year-over-year, with the annual reading at -$131.0 million for FY2025, 64.78% up from the prior year.
  • Other financing activities was -$80.0 million for Q1 2026 at Merck, down from $121.0 million in the prior quarter.
  • Over five years, Other financing activities peaked at $121.0 million in Q4 2025 and troughed at -$234.0 million in Q2 2023.
  • The 5-year median for Other financing activities is -$68.0 million (2022), against an average of -$67.7 million.
  • Year-over-year, Other financing activities plummeted 1300.0% in 2024 and then soared 388.1% in 2025.
  • A 5-year view of Other financing activities shows it stood at -$68.0 million in 2022, then surged by 95.59% to -$3.0 million in 2023, then plummeted by 1300.0% to -$42.0 million in 2024, then skyrocketed by 388.1% to $121.0 million in 2025, then crashed by 166.12% to -$80.0 million in 2026.
  • Per Business Quant, the three most recent readings for MRK's Other financing activities are -$80.0 million (Q1 2026), $121.0 million (Q4 2025), and $2.0 million (Q3 2025).